Radiopharm Theranostics: Developing a portfolio of assets targeting cancer
Radiopharm Theranostics Limited CEO and Managing Director Riccardo Canevari provides an update on the company’s pipeline and discusses the recent licensing of an asset from UCLA.
Read More